Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BEIERSDORF AKTIENGESELLSCHAFT

(BEI)
  Report
Delayed Quote. Delayed Xetra - 01/21 11:35:12 am
90.38 EUR   +0.04%
01/20NEW SUPERSTAR IN ANTI-AGE SKIN CARE : Bakuchiol
PU
01/20BEIERSDORF AG : Buy rating from Berenberg
MD
01/18BEIERSDORF AG : UBS remains a Sell rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Beiersdorf : Researches the Skin's Biological Clock

11/16/2021 | 06:06am EST

Currently, ageing research is experiencing a real hype. All over the world, clever minds are searching for the formula for the dream of eternal life. The aim is rather to push back natural boundaries in favor of better health. In terms of the largest human organ, Beiersdorf researchers are at the forefront. This year, they have taken decisive steps in the development of a technology that can be used to accurately predict the biological age of the skin.

"With our biological clock, we have a key technology at our disposal. We didn't fully grasp this at first," admits Dr. Marc Winnefeld, Head of Applied Skin Research at Beiersdorf. In the meantime, he and his team have immersed themselves deeply in the subject. The researchers are certain that the breakthrough will come sooner or later: "We don't have a crystal ball, but it's certainly only a matter of time before we can develop innovative cosmetic products that not only slow down the aging process, but also turn back the skin's biological clock to improve skin functions in the long term."

Disclaimer

Beiersdorf AG published this content on 16 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 November 2021 11:05:02 UTC.


ę Publicnow 2021
All news about BEIERSDORF AKTIENGESELLSCHAFT
01/20NEW SUPERSTAR IN ANTI-AGE SKIN CARE : Bakuchiol
PU
01/20BEIERSDORF AG : Buy rating from Berenberg
MD
01/18BEIERSDORF AG : UBS remains a Sell rating
MD
01/18BEIERSDORF AG : JP Morgan remains Neutral
MD
01/18BEIERSDORF AG : Raised to Buy by Deutsche Bank
MD
01/12Beiersdorf Investing in Start-up for Digital Dermatologist Appointments
AQ
01/11BEIERSDORF AG : Gets a Buy rating from DZ Bank
MD
01/11BEIERSDORF AG : Jefferies maintains a Buy rating
MD
01/05BEIERSDORF AG : Bernstein reaffirms its Neutral rating
MD
2021StoneCo Reportedly Hires JPMorgan To Explore Strategic Options; Shares Launched to One-..
MT
More news
Analyst Recommendations on BEIERSDORF AKTIENGESELLSCHAFT
More recommendations
Financials
Sales 2021 7 611 M 8 633 M 8 633 M
Net income 2021 661 M 750 M 750 M
Net cash 2021 3 033 M 3 440 M 3 440 M
P/E ratio 2021 31,0x
Yield 2021 0,78%
Capitalization 20 500 M 23 250 M 23 253 M
EV / Sales 2021 2,29x
EV / Sales 2022 2,10x
Nbr of Employees 20 465
Free-Float -
Chart BEIERSDORF AKTIENGESELLSCHAFT
Duration : Period :
Beiersdorf Aktiengesellschaft Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIERSDORF AKTIENGESELLSCHAFT
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 90,38 €
Average target price 102,63 €
Spread / Average Target 13,6%
EPS Revisions
Managers and Directors
Vincent Warnery Chairman-Executive Board
Astrid Hermann Chief Financial Officer
Reinhard P÷llath Chairman-Supervisory Board
Gitta Neufang Manager-Research Diseased Skin
Manuela Rousseau Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BEIERSDORF AKTIENGESELLSCHAFT0.00%23 250
PROCTER & GAMBLE COMPANY-0.59%389 811
UNILEVER PLC-6.86%127 583
THE ESTÉE LAUDER COMPANIES INC.-18.68%106 912
HINDUSTAN UNILEVER LIMITED-1.59%73 415
COLGATE-PALMOLIVE COMPANY-2.40%70 521